CD276 and neoplasm: Both studies showed that silencing B7-H3 significantly enhanced tumor cell chemosensitivity and drug-induced apoptosis, thus providing a rationale for the potential synergistic effects between the B7-H3 blockade and chemotherapy or targeted therapy for patients with a variety of cancers.